When was ibrutinib launched?

Ibrutinib was approved by the United States in 2016FDAwas approved for marketing, and 2017June Menstruation was approved for marketing by China Food and Drug Administration. Ibrutinib is a kinase inhibitor indicated for the treatment of adult patients with chronic lymphocytic leukemia(CLL)/small lymphocytic lymphoma(SLL). Treatment of adult patients with chronic lymphocytic leukemia(CLL)/small lymphocytic lymphoma(SLL) with 17p deletion. For the treatment of adult patients with Waldenströmacroglobulinemia(WM). For use in adult and pediatric patients 1 year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more systemic therapies.

In a mouse mantle cell dissemination and progression model,ibrutinib inhibits malignant cell adhesion and migration and reduces tumor burden in lymph nodes and bone marrow. Ibrutinib is a kinase inhibitor. It is a white to off-white solid with the empirical formula C25H24N6O2 and a molecular weight of 440.50. IbrutinibEasily soluble in dimethyl sulfoxide, soluble in methanol, and almost insoluble in water. The chemical name of ibrutinib is 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3, 4-d]pyrimidine-1-yl]-1-piperidinyl]-2-propene-1-one. Ibrutinib oral capsules are available in the following dose strengths: 70 mg and 140 mg. Each capsule contains ibrutinib (active ingredient) and the following inactive ingredients: croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. The capsule shell contains gelatin, titanium dioxide, yellow iron oxide(only70mg capsule)and black ink. There are generic drugs in Bangladesh, Laos and India. Different manufacturers have different specifications and prices. The price per box is about 1000 to 2000 more. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.